The original front doors of The Johns Hopkins Hospital. The key was used only once, as the doors were always open to anyone in need.

For more than twenty-five years, the Johns Hopkins Clinical Pharmacology Postdoctoral Fellowship has prepared fellows to advance the study and use of medicines. Its graduates have gone on to prominent leadership roles in academia, government, and industry. The NIH T32–supported fellowship builds on the work of the Division of Clinical Pharmacology, which has contributed to drug development since its founding in 1954.

Fellows draw on clinical medicine, laboratory science, and quantitative methods through advanced coursework, rotations, and faculty-mentored clinical and translational research. The Division’s Drug Development Unit provides a dedicated setting for early-phase clinical trials. Fellows may pursue a master’s degree or PhD through the Graduate Training Programs in Clinical Investigation.

We seek physicians, pharmacists, and scientists with demonstrated research initiative and interest in phase I and II clinical trials, pharmacometrics, pharmacovigilance, or pharmacoepidemiology. Physicians who combine clinical pharmacology with specialty training typically join our program after starting a fellowship in oncology, infectious diseases, obstetrics and gynecology, gastroenterology, ophthalmology or other clinical specialty.

Applicants are asked to submit a completed questionnaire, curriculum vitae, three letters of recommendation, and a one-page personal statement of research interests via the online application. US Citizens or permanent residents may be eligible for funding by our NIH-supported T32 Clinical Pharmacology Training Program. Others may be funded by ongoing research programs or other sources of fellowship support.